Frontlight ResearchEarly access
Schizophrenia trials in Bosnia & Herzegovina
1 trial · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleQuality of Life, Safety and Compliance of Patients Using Monotherapy or Combinatorial Therapy With Quetiapine for Treatment of Schizophrenia or Bipolar Affective Disorder
- Where
- Sarajevo
- Age
- 18 years to 65 years
- People
- 500
- Run by
- Bosnalijek D.D
See details and how to joinNCT07858565